Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Depreciation & Amortization (CF) (2020 - 2025)

BioAtla (BCAB) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with $19000.0 as the latest value for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 91.67% year-over-year to $19000.0; the TTM value through Dec 2025 reached $373000.0, down 59.68%, while the annual FY2025 figure was $373000.0, 59.68% down from the prior year.
  • Depreciation & Amortization (CF) hit $19000.0 in Q4 2025 for BioAtla, down from $56000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $380000.0 in Q3 2021 and bottomed at $19000.0 in Q4 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $252400.0, with a median of $289000.0 recorded in 2022.
  • Year-over-year, Depreciation & Amortization (CF) surged 52.09% in 2021 and then tumbled 91.67% in 2025.
  • BioAtla's Depreciation & Amortization (CF) stood at $314000.0 in 2021, then fell by 5.1% to $298000.0 in 2022, then rose by 23.49% to $368000.0 in 2023, then tumbled by 38.04% to $228000.0 in 2024, then crashed by 91.67% to $19000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $19000.0, $56000.0, and $115000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.